Items where authors include "Evans, T.R.J."

Article

Rekowski, J. orcid.org/0000-0002-5207-3864, Guo, C., Solovyeva, O. et al. (35 more authors) (2025) CONSORT-DEFINE explanation and elaboration: recommendations for enhancing reporting quality and impact of early phase dose-finding clinical trials. eClinicalMedicine, 79. 102987. ISSN 2589-5370

Ursino, M., Villacampa, G., Rekowski, J. orcid.org/0000-0002-5207-3864 et al. (34 more authors) (2025) SPIRIT-DEFINE explanation and elaboration: recommendations for enhancing quality and impact of early phase dose-finding clinical trials protocols. eClinicalMedicine, 79. 102988. ISSN 2589-5370

Sacco, J.J., Jackson, R., Corrie, P. et al. (18 more authors) (2024) A three-arm randomised phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel in metastatic uveal melanoma. European Journal of Cancer, 202. 114009. ISSN 0959-8049

Yap, C. orcid.org/0000-0002-6715-2514, Rekowski, J. orcid.org/0000-0002-5207-3864, Ursino, M. orcid.org/0000-0002-5709-4322 et al. (32 more authors) (2023) Enhancing quality and impact of early phase dose-finding clinical trial protocols: SPIRIT dose-finding extension (SPIRIT-DEFINE) guidance. BMJ, 383. e076386. ISSN 1759-2151

Yap, C. orcid.org/0000-0002-6715-2514, Solovyeva, O. orcid.org/0000-0001-7828-4099, de Bono, J. orcid.org/0000-0002-2034-595X et al. (32 more authors) (2023) Enhancing reporting quality and impact of early phase dose-finding clinical trials: CONSORT dose-finding extension (CONSORT-DEFINE) guidance. BMJ, 383. e076387. ISSN 0959-8138

Kristeleit, R. orcid.org/0000-0003-3825-1326, Plummer, R., Jones, R. et al. (11 more authors) (2023) A Phase 1/2 trial of SRA737 (a Chk1 inhibitor) administered orally in patients with advanced cancer. British Journal of Cancer, 129. pp. 38-45. ISSN 0007-0920

Solovyeva, O. orcid.org/0000-0001-7828-4099, Dimairo, M. orcid.org/0000-0002-9311-6920, Weir, C.J. orcid.org/0000-0002-6494-4903 et al. (20 more authors) (2023) Development of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE study. BMC Medicine, 21 (1). 246. ISSN 1741-7015